Kim D. Blickenstaff, Director at TANDEM DIABETES CARE INC (TNDM), sold 566,284 shares at $108.58 ($60.0M) on 2020-08-07, disclosed to the SEC on 2020-08-10.
Open-market sale of $60.0M TNDM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.65 | 121,698 | $12.9M | 21.4% |
| 2 | $105.65 | 121,698 | $12.9M | 21.4% |
| 3 | $107.07 | 600 | $64K | 0.1% |
| 4 | $107.07 | 600 | $64K | 0.1% |
| 5 | $105.86 | 117,897 | $12.5M | 20.8% |
| 6 | $105.86 | 117,897 |
| $12.5M |
| 20.8% |
| 7 | $106.94 | 25,108 | $2.7M | 4.5% |
| 8 | $106.94 | 25,108 | $2.7M | 4.5% |
| 9 | $107.65 | 17,439 | $1.9M | 3.1% |
| 10 | $107.65 | 17,439 | $1.9M | 3.1% |
| 11 | $108.58 | 800 | $87K | 0.1% |
| Total | $105.98 avg | 566,284 | $60.0M | 100% |
| Filing → |
| TNDM | SELL | 2022-05-19 | $2.0M | — | Filing → |
| TNDM | SELL | 2021-09-03 | $3.3M | — | Filing → |
| TNDM | SELL | 2021-08-18 | $8.8M | — | Filing → |